← All IPOs

Himalaya Nutravedics IPO Allotment Status

SMEBidding closed
HNIL · Pharmaceuticals · NSE SME

Checked · GMP unchanged since

Himalaya Nutravedics IPO Details

RegistrarKfin Technologies Limited
Lead managersNirbhay Capital Services Private Limited
Offer documentDraft (DRHP)
Fresh issue₹26.5 Cr
Offer for sale—

Himalaya Nutravedics Financials ₹ in crore

Detailed financials for this issue aren’t available yet.

Himalaya Nutravedics IPO Lot Size & Minimum Investment by investor category

ApplicationSharesAmount at ₹106
Individual investor (min)minimum application2,400₹2,54,400

The minimum application is 2,400 shares, ₹2,54,400 at the ₹106 cut-off. Since 1 July 2025 SME issues take a minimum application of ₹2,00,000 or more from individual investors; the HNI minimum is set in the RHP. Amounts are shown at the upper band because applications are made at the cut-off price.

About Himalaya Nutravedics

Himalaya Nutravedics India Limited manufactures and markets Ayurvedic and Nutraceutical formulations in India. It also undertakes third-party contract manufacturing. The company's product portfolio includes classical Ayurvedic formulations, proprietary Ayurvedic formulations, and nutraceutical supplements across multiple dosage forms. Its products are used in areas such as digestive health, immunity, metabolic health, and general wellness. The company was incorporated in 2022.

Himalaya Nutravedics IPO Strengths & Risks as disclosed in the DRHP

Strengths and risk factors from this issue’s prospectus aren’t available yet.

How to check Himalaya Nutravedics IPO allotment status

Allotment is decided and published by the issue’s registrar, not by the exchange and not by alphave. For Himalaya Nutravedics, the registrar is Kfin Technologies Limited — allotment is finalised in the days between the issue closing on 24 Sept 2026 and listing on 29 Sept 2026.

RegistrarKfin Technologies Limited
You will needPAN, application number or demat ID
Issue closes24 Sept 2026
Listing date29 Sept 2026
Issue opens
Tue, 22 Sept, 2026
Bidding 10:00 am – 5:00 pm IST
Issue closes
Thu, 24 Sept, 2026
Last day to bid · UPI mandate by 5:00 pm
Allotment finalisedTentative
Fri, 25 Sept, 2026
By Kfin Technologies; check with PAN, application no. or DP ID
Refunds & UPI unblockTentative
Mon, 28 Sept, 2026
Unallotted amounts released · allotted shares credited to demat
Listing
Tue, 29 Sept, 2026
NSE SME · trading from 10:00 am IST

Allotment and refund dates follow SEBI’s T+3 listing timeline in trading days and are tentative until the registrar and the exchange confirm them. alphave does not hold allotment results — only the registrar can show whether an application was allotted.

The registrar publishes allotment on its own portal: KFintech. Your bank will also show the blocked amount released if shares were not allotted.

Himalaya Nutravedics IPO Allotment Status FAQs

When is Himalaya Nutravedics IPO allotment date?

Allotment for the Himalaya Nutravedics IPO is expected to be finalised on 25 September 2026, the trading day after the issue closes on 24 September 2026. Under SEBI's T+3 timeline refunds and demat credit follow on 28 September 2026 and the shares list on 29 September 2026. Dates are tentative until the registrar and exchange confirm them.

How to check Himalaya Nutravedics IPO allotment status?

Allotment is decided and published by the registrar, Kfin Technologies Limited — not by the exchange and not by alphave. Open the registrar's IPO allotment page, choose the issue, and enter your PAN, application number or DP ID / client ID. Your bank will also show the blocked amount released if shares were not allotted.

Who is the registrar of Himalaya Nutravedics IPO?

The registrar to the Himalaya Nutravedics IPO is Kfin Technologies Limited. The registrar processes applications, finalises the basis of allotment with the exchange, and handles refunds.

What happens if I do not get allotment?

The amount blocked in your bank account under ASBA or the UPI mandate is released, normally on the day allotment is finalised or the next working day. No shares are credited and nothing further is needed from you.

Himalaya Nutravedics IPO Registrar where allotment and refund queries go

RegistrarKfin Technologies Limited

The registrar processes the allotment and the refunds. Contact details are as printed in the offer document; the exchange and your broker cannot change an allotment.

How to Apply for the Himalaya Nutravedics IPO ASBA and UPI, as SEBI sets them

  1. Apply through your broker’s IPO window or your bank’s net banking (ASBA). The money stays in your own account and is only blocked until allotment.
  2. Choose the number of lots and bid at the cut-off price. SME issues take a minimum application of two lots, so the smallest valid bid is the amount shown in the lot table above.
  3. If you applied through a broker, approve the UPI mandate in your payment app. The mandate must be approved by 5 pm on the day after your bid, and by 5 pm on the closing day for bids made on the last day (24 Sept 2026).
  4. One application per PAN. A second application under the same PAN is rejected, and both may be.
  5. After allotment the blocked amount is released for shares not allotted. Allotment and refund queries go to the registrar, Kfin Technologies Limited, not to the exchange or the broker.

What is GMP in an IPO?

Grey Market Premium is the price at which an unlisted IPO application or share changes hands informally, before the stock is listed on the exchange. It is quoted as a rupee figure over the issue price: a premium of ₹0 on a ₹106 upper band means the grey market is dealing at ₹106.

The grey market is an over-the-counter market between private dealers. It is not operated or supervised by NSE, BSE or SEBI, no trade is settled through a clearing corporation, and no dealer is obliged to publish or honour a quote. Figures are collected by third-party reporters and different sources routinely disagree, which is why a premium can move sharply within a day or vanish entirely once bidding closes.

Grey Market Premium is an unofficial, unregulated over-the-counter datapoint reported by third parties. It is not a price, a forecast, or an indication of listing gains, and is not investment advice.